Shareholder Suits Over Genoptix Sale Consolidated
A California federal judge on Wednesday consolidated two investor class actions against laboratory services company Genoptix Inc., which Novartis AG agreed to buy for $470 million in January, and appointed Robbins...To view the full article, register now.
Already a subscriber? Click here to view full article